DVAX
Dynavax Technologies Corp
Price:  
10.42 
USD
Volume:  
2,364,799.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DVAX Relative Valuation

-98.1%
Upside

As of 2025-05-21, the Relative Valuation of Dynavax Technologies Corp (DVAX) is 0.20 USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.42 USD, the upside of Dynavax Technologies Corp based on Relative Valuation is -98.1%.

The range of the Relative Valuation is (8.25) - 10.31 USD.

Range Selected
Trailing P/E multiples 16.8x - 22.9x 19.8x
Forward P/E multiples 29.9x - 30.9x 30.4x
Fair Price (8.25) - 10.31 0.20
Upside -179.2% - -1.0% -98.1%
10.42 USD
Stock Price
0.20 USD
Fair Price

DVAX Relative Valuation - Historical P/E Data

Date P/E
2025-05-16 -19.71
2025-05-15 -19.38
2025-05-14 -19.16
2025-05-13 -19.60
2025-05-12 -20.07
2025-05-09 -19.18
2025-05-08 -19.75
2025-05-07 -19.81
2025-05-06 -22.25
2025-05-05 -22.95
2025-05-02 -23.09
2025-05-01 -23.39
2025-04-30 -23.94
2025-04-29 -23.54
2025-04-28 -22.97
2025-04-25 -22.05
2025-04-24 -22.21
2025-04-23 -21.95
2025-04-22 -21.85
2025-04-21 -21.27
2025-04-17 -21.01
2025-04-16 -21.70
2025-04-15 -23.25
2025-04-14 -23.31
2025-04-11 -22.93
2025-04-10 -22.35
2025-04-09 -24.52
2025-04-08 -23.94
2025-04-07 -25.45
2025-04-04 -25.78
2025-04-03 -26.19
2025-04-02 -26.23
2025-04-01 -25.90
2025-03-31 -26.43
2025-03-28 -27.88
2025-03-27 -27.96
2025-03-26 -27.67
2025-03-25 -28.49
2025-03-24 -28.20
2025-03-21 -28.16
2025-03-20 -27.76
2025-03-19 -27.80
2025-03-18 -28.33
2025-03-17 -27.78
2025-03-14 -28.26
2025-03-13 -27.90
2025-03-12 -28.00
2025-03-11 -28.10
2025-03-10 -29.32
2025-03-07 -29.34